Biotechnology & Drugs news, Biotechnology & Drugs industry, industry News

▮ More

Healthcare Stocks That Hit New Highs (DXCM, ZLAB, PODD)

Keep An Eye On BREW, ICUI, GO…

AstraZeneca Reports Positive TULIP 2 Trial For Anifrolumab To Treat SLE

AstraZeneca Presents Results From Positive Phase 3 TULIP 2 Trial For Anifrolumab

ASLN Slumps As TreeTopp Flops, CSTL On Watch, KDMN Rocks, NXTC Down 53%

Sandoz's Data Shows Effectiveness Of Erelzi In Rheumatic Disease Treatment

Novartis: Phase III PREVENT Trial Met Primary Endpoint Of ASAS40 At Week 16

Sandoz Presents Interim Analysis From COMPACT Study

Novartis Announces Detailed Results From Phase III PREVENT Trial

MorphoSys's Partner Presents Results For Bimagrumab In Obesity, Type 2 Diabetes

Today's Top 5 Gainers In Healthcare Sector (CABA, INMD, AQST…)

FDA Approves Celegene's Reblozyl To Treat An Inherited Blood Disorder

Allergan Gets FDA QIDP Designation And Fast Track Designation For ATM-AVI

FDA Rejects Lipocine's TLANDO Yet Again

Lipocine Receives Complete Response Letter From FDA For TLANDO - Quick Facts

Foamix Pharm And Menlo Therapeutics To Merge - Quick Facts

What Awaits ASMB, DRRX, EIGR At The Liver Meeting?

Keep An Eye On ATNX, OCUL, SGMS…

AstraZeneca: Roxadustat Phase III Pooled Analyses Show Positive Efficacy

Beximco Pharma FY Net Sales Up 28.8% To £212.7 Mln

Eco Animal Health Says H1 Trading Results To Be Below Last Year

Sandoz To Buy Aspen's Japanese Unit For Initial Cash Payment Of EUR 300 Mln

Roche : Phase II Study On Proliferative Lupus Nephritis Meets Primary Endpoint

Genentech: Risdiplam Trial Meets Primary Goal In People With Type 2 Or 3 SMA

Sandoz Agrees To Acquire Aspen's Japanese Operations And Associated Assets

Industries >>

Biotechnology & Drugs News

AstraZeneca Presents Results From Positive Phase 3 TULIP 2 Trial For Anifrolumab

Sandoz Presents Interim Analysis From COMPACT Study

Novartis Announces Detailed Results From Phase III PREVENT Trial

Beximco Pharma FY Net Sales Up 28.8% To £212.7 Mln

Eco Animal Health Says H1 Trading Results To Be Below Last Year

Sandoz Agrees To Acquire Aspen's Japanese Operations And Associated Assets